Danaher Corporation (DHR) is a publicly traded company in the Healthcare sector, operating within the Medical - Diagnostics & Research industry. The company is headquartered in Washington, DC, United States. The current CEO is Rainer Blair.
DHR has IPO date of 1978-12-29, 61,000 full-time employees, listed on the NYSE, a market capitalization of $140.44B.
Danaher Corporation is a global manufacturer of professional, medical, industrial, and commercial products and services headquartered in Washington, D.C. The company operates three primary business segments: Life Sciences, which provides mass spectrometers, flow cytometry, genomics, lab automation, and bioprocess technologies serving pharmaceutical, biopharmaceutical, and research institutions; Diagnostics, which offers clinical chemistry, immunoassay, hematology, and molecular diagnostic systems for hospitals and laboratories; and Environmental & Applied Solutions, which provides water analysis and treatment instrumentation alongside color management and product packaging solutions. With a diversified portfolio spanning life sciences research, clinical diagnostics, and environmental monitoring, Danaher serves customers across healthcare, pharmaceutical, food and beverage, and industrial sectors worldwide. Founded in 1969, the company has established itself as a leader in analytical and diagnostic technologies.